ETF日报：创新药板块或存在盈利和估值抬升的可能，值得关注

Market Overview - The A-share market showed weakness today, influenced by a drop of over 2% in the Nasdaq, with the Shanghai Composite Index closing at 3990.49 points, down 0.97% [1] - The Shenzhen Component fell by 1.93%, and the ChiNext Index dropped by 2.82%, with more than 3300 stocks declining [1] - Trading volume in both markets was below 2 trillion yuan, indicating a lack of activity [1] Sector Performance - Only sectors such as oil and petrochemicals, real estate, banking, and pharmaceuticals showed resilience, while other sectors, particularly AI, communications, and chips, experienced significant declines [1] - The recent fluctuations in the global market have led to a cautious sentiment among domestic investors, raising concerns about whether A-shares will follow the downward trend of overseas markets [1][2] Economic Indicators - Key credit indicators like social financing have shown mediocre performance, indicating a lag in the recovery of confidence in the real economy [5] - In October, new RMB loans amounted to 220 billion yuan, a decrease of 280 billion yuan year-on-year, while social financing increased by 815 billion yuan, down 597 billion yuan year-on-year [5] Investment Sentiment - The current market sentiment is influenced by short-term risk preferences and trading emotions, with a belief that domestic market logic will eventually prevail [2][4] - The ongoing economic stabilization and supportive policies are expected to provide a foundation for valuation levels, suggesting that recent pullbacks could present buying opportunities [4] AI and Innovation Sector - The AI sector faces uncertainties regarding revenue contributions and high capital expenditures, with many companies still in the investment phase and struggling to achieve stable profitability [6] - The introduction of AI in drug discovery and development is seen as a significant opportunity, with potential for increased efficiency and reduced costs in the pharmaceutical industry [12][13] Gold Market - The gold market has shown strong performance compared to equity markets, with recent geopolitical tensions and economic uncertainties driving demand for gold as a safe-haven asset [15][16] - The long-term outlook for gold remains positive due to systemic risks, including inflation and geopolitical tensions, which are expected to support gold prices [16]